116 related articles for article (PubMed ID: 22343681)
1. Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype.
Thachil J; Martlew V
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):232-4. PubMed ID: 22343681
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
3. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
4. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
[TBL] [Abstract][Full Text] [Related]
5. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
[TBL] [Abstract][Full Text] [Related]
7. Determinants of bleeding severity in von Willebrand disease.
Di Paola J
Curr Hematol Rep; 2005 Sep; 4(5):345-9. PubMed ID: 16131434
[TBL] [Abstract][Full Text] [Related]
8. Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Baronciani L; Federici AB; Cozzi G; La Marca S; Punzo M; Rubini V; Canciani MT; Mannucci PM
Haemophilia; 2008 May; 14(3):549-55. PubMed ID: 18328061
[TBL] [Abstract][Full Text] [Related]
9. Type 2B von Willebrand disease in seven individuals from three different families: phenotypic and genotypic characterization.
Szántó T; Schlammadinger A; Salles I; Pareyn I; Vauterin S; Hársfalvi J; Vanden Bulcke AM; Deckmyn H; Vanhoorelbeke K
Thromb Haemost; 2007 Jul; 98(1):251-4. PubMed ID: 17598021
[No Abstract] [Full Text] [Related]
10. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant von Willebrand disease type 2M.
Hermans C; Batlle J
Acta Haematol; 2009; 121(2-3):139-44. PubMed ID: 19506360
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
[TBL] [Abstract][Full Text] [Related]
13. Management of inherited von Willebrand disease in 2007.
Federici AB; Mannucci PM
Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
[TBL] [Abstract][Full Text] [Related]
15. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
Favaloro EJ
Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
[No Abstract] [Full Text] [Related]
17. Inherited and de novo von Willebrand disease 'Vicenza' in UK families with the R1205H mutation: diagnostic pitfalls and new insights.
Lester WA; Guilliatt AM; Surdhar GK; Enayat SM; Wilde JT; Willoughby S; Grundy P; Cumming AM; Collins PW; Hill FG
Br J Haematol; 2006 Oct; 135(1):91-6. PubMed ID: 16925796
[TBL] [Abstract][Full Text] [Related]
18. Gene conversions are a common cause of von Willebrand disease.
Gupta PK; Adamtziki E; Budde U; Jaiprakash M; Kumar H; Harbeck-Seu A; Kannan M; Oyen F; Obser T; Wedekind I; Saxena R; Schneppenheim R
Br J Haematol; 2005 Sep; 130(5):752-8. PubMed ID: 16115133
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of inherited von Willebrand disease: a clinical perspective.
Federici AB
Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
[TBL] [Abstract][Full Text] [Related]
20. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation.
Castaman G; Eikenboom JC; Bertina RM; Rodeghiero F
Thromb Haemost; 1999 Sep; 82(3):1065-70. PubMed ID: 10494765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
